237 related articles for article (PubMed ID: 34369535)
1. Delivery of a system x
Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
[TBL] [Abstract][Full Text] [Related]
2. Oxygen Self-Supplied Perfluorocarbon-Modified Micelles for Enhanced Cancer Photodynamic Therapy and Ferroptosis.
Ren H; Hao M; Liu G; Li J; Jiang Z; Meng W; Zhang Y
ACS Appl Bio Mater; 2024 May; 7(5):3306-3315. PubMed ID: 38634490
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy.
Pei Q; Lu S; Zhou J; Jiang B; Li C; Xie Z; Jing X
ACS Appl Mater Interfaces; 2021 Dec; 13(50):59708-59719. PubMed ID: 34879654
[TBL] [Abstract][Full Text] [Related]
4. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
5. Highly Stable Silica-Coated Bismuth Nanoparticles Deliver Tumor Microenvironment-Responsive Prodrugs to Enhance Tumor-Specific Photoradiotherapy.
Xiang H; Wu Y; Zhu X; She M; An Q; Zhou R; Xu P; Zhao F; Yan L; Zhao Y
J Am Chem Soc; 2021 Aug; 143(30):11449-11461. PubMed ID: 34292717
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
7. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
8. Traceable Nanocluster-Prodrug Conjugate for Chemo-photodynamic Combinatorial Therapy of Non-small Cell Lung Cancer.
Srinivasulu YG; Mozhi A; Goswami N; Yao Q; Xie J
ACS Appl Bio Mater; 2021 Apr; 4(4):3232-3245. PubMed ID: 35014410
[TBL] [Abstract][Full Text] [Related]
9. A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models.
Spangler B; Fontaine SD; Shi Y; Sambucetti L; Mattis AN; Hann B; Wells JA; Renslo AR
J Med Chem; 2016 Dec; 59(24):11161-11170. PubMed ID: 27936709
[TBL] [Abstract][Full Text] [Related]
10. Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy.
Song Y; Sun Y; Tang M; Yue Z; Ni J; Zhao J; Wang W; Sun T; Shi L; Wang L
ACS Appl Mater Interfaces; 2022 Feb; 14(4):4914-4920. PubMed ID: 35050579
[TBL] [Abstract][Full Text] [Related]
11. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
[TBL] [Abstract][Full Text] [Related]
12. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z
Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949
[TBL] [Abstract][Full Text] [Related]
13. Aminoferrocene-based prodrugs activated by reactive oxygen species.
Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
[TBL] [Abstract][Full Text] [Related]
14. 4-Azidobenzyl ferrocenylcarbamate as an anticancer prodrug activated under reductive conditions.
Kinski E; Marzenell P; Hofer W; Hagen H; Raskatov JA; Knaup KX; Zolnhofer EM; Meyer K; Mokhir A
J Inorg Biochem; 2016 Jul; 160():218-24. PubMed ID: 26970945
[TBL] [Abstract][Full Text] [Related]
15. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy.
Lu Y; Jia D; Ma X; Liang M; Hou S; Qiu W; Gao Y; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2021 Feb; 13(7):8940-8951. PubMed ID: 33565847
[TBL] [Abstract][Full Text] [Related]
16. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
17. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
18. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN
Liang YX; Sun XY; Xu DZ; Gao YN; Tang Q; Lu ZL; Liu Y
ACS Appl Bio Mater; 2024 May; 7(5):3202-3214. PubMed ID: 38651918
[TBL] [Abstract][Full Text] [Related]
19. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy.
Gu G; Chen C; Zhang S; Yin B; Wang J
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50682-50694. PubMed ID: 34668695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
